The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution   Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)     David McDermott Consulting or Advisory Role - alkermes; Arcus Biosciences; Bristol-Myers Squibb; Cullinan Oncology; Eisai; EMD Serono; exelixis; Iovance Biotherapeutics; Lilly; Merck; Pfizer; Synthekine; Werewolf Therapeutics; Xilio Therapeutics Research Funding - alkermes (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Novartis (Inst) Other Relationship - Beth Israel Deaconess Medical Center   Avivit Peer Honoraria - Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen Oncology; Medison; Merck Serono; MSD; Novartis; Pfizer; Roche Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen-Cilag; Merck Serono; MSD Oncology; Novartis; Pfizer Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; MSD Oncology; Pfizer   Howard Gurney Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen-Cilag; Merck Serono; Merck Sharp & Dohme; Pfizer; Roche Speakers' Bureau - Astellas Pharma; AstraZeneca; Ipsen; Merck Serono   Azim Khan Travel, Accommodations, Expenses - MSD Oncology; Regeneron   Victoria Neiman Honoraria - Astellas Pharma; BMS; MSD; Pfizer   Babak Tamjid Research Funding - Merck Sharp & Dohme   Jonathan Trujillo Research Funding - Merck Sharp & Dohme Travel, Accommodations, Expenses - DAVA Oncology   Tania Moujaber Honoraria - Eisai Consulting or Advisory Role - Bayer; Bristol-Myers Squibb/Sanofi; Merck/Pfizer   Hadas Dresler Research Funding - Merck Sharp & Dohme   Benjamin Maughan Consulting or Advisory Role - Arcus Biosciences; Astellas Medivation; AVEO; Bavarian Nordic; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; Exelixis; Janssen Oncology; Lilly; Merck; Peloton Therapeutics; Pfizer; Sanofi; Telix Pharmaceuticals; Tempus; Xencor Research Funding - Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Exelixis (Inst) Travel, Accommodations, Expenses - Exelixis   Jerry Cornell Employment - Merck Stock and Other Ownership Interests - Merck   Rodolfo Perini Employment - Merck Stock and Other Ownership Interests - Merck   Ali Rana Employment - Merck Stock and Other Ownership Interests - Merck   Michael Atkins Leadership - Werewolf Therapeutics Stock and Other Ownership Interests - Pyxis; Werewolf Pharma Consulting or Advisory Role - Abbvie; Agenus; AstraZeneca; Aveo; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Delcath Systems; Eisai; Exelixis; Genentech; Handa Oncology; Innovent Biologics; IO Biotech; Jazz Pharmaceuticals; Merck; Novartis; Oncorena; Pfizer; Pliant; Pyxis; Replimune; SeaGen; Simcha Therapeutics; Syncona; Werewolf Pharma Research Funding - Agenus (Inst); Bristol-Myers Squibb (Inst); Merck (Inst) Travel, Accommodations, Expenses - BMS Canada; BMS Sweden